Medicare Enrolled

Dr. Robert Wong, MD

Ophthalmology · Austin, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
801 W 38TH ST, Austin, TX 78705
5124510103
In practice since 2006 (19 years)
NPI: 1275699274 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wong from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wong? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wong

Dr. Robert Wong is an ophthalmology in Austin, TX, with 19 years in practice. Based on federal Medicare data, Dr. Wong performed 32,276 Medicare services across 3,955 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wong received a total of $112,670 from 33 pharmaceutical and/or device companies across 164 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wong is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 2% volume in TX$ $112,670 industry payments

Medicare Practice Summary

Medicare Utilization ↗
32,276
Medicare services
Top 2% in TX for ophthalmology
3,955
Unique beneficiaries
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,699 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Eye injection (Vabysmo/faricimab)21,720$29$84
Aflibercept eye injection (Eylea)2,274$692$2,000
Retinal imaging (OCT scan)2,215$28$125
Eye injection for retinal disease1,635$97$550
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg753$217$1,000
Office visit, established patient (20-29 min)656$59$200
Comprehensive eye exam, established patient506$88$265
Exam of retinal blood vessels using a special camera after injection of a dye478$107$270
Retinal photography (fundus photo)444$27$95
Injection, pegcetacoplan, intravitreal, 1 mg360$120$336
Injection, ranibizumab, 0.1 mg282$189$877
Office visit, established patient (30-39 min)217$86$270
Injection, dexamethasone, intravitreal implant, 0.1 mg196$159$400
Comprehensive eye exam, new patient141$99$315
Injection, bevacizumab, 10 mg136$56$150
Unclassified drugs89$1,703$4,761
Eye exam, established patient, focused84$62$190
New patient office visit (45-59 min)58$122$350
2d ultrasound scan of eye tissue and structures21$37$150
Removal of eye fluid (vitreous) between lens and retina11$727$1,820
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$112,670
Total received (2018-2024)
Avg $16,096/year across 7 years
Top 3% in TX for ophthalmology
33
Companies
164
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$100,860 (89.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,778 (6.0%)
Other
Charitable contributions, space rental, and other categories
$3,437 (3.1%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$894 (0.8%)
Scientific / Research
Research funding and grants
$595 (0.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$106 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,122
2023
$49,131
2022
$57,555
2021
$568
2020
$550
2019
$1,707
2018
$1,036

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Baxter Healthcare
$97,590
US Retina LLC
$4,331
Novartis Pharmaceuticals Corporation
$3,370
Genentech USA, Inc.
$906
Regeneron Healthcare Solutions, Inc.
$767
Apellis Pharmaceuticals, Inc.
$640
ABBVIE INC.
$595
Alcon Vision LLC
$482
Regeneron Pharmaceuticals, Inc.
$434
Alcon Laboratories Inc
$383
Johnson & Johnson Surgical Vision, Inc.
$381
Allergan Inc.
$293
Genentech, Inc.
$240
Mallinckrodt Hospital Products Inc.
$240
TissueTech, Inc.
$205
Astellas Pharma US Inc
$190
EyePoint Pharmaceuticals US, Inc.
$188
Carl Zeiss Meditec, Inc.
$176
Bausch & Lomb Americas Inc.
$175
Alimera Sciences, Inc.
$155
Optos, Inc.
$144
Astellas Pharma Global Development
$131
RxSight Inc
$127
Mallinckrodt Enterprises LLC
$119
Amgen Inc.
$108
OPTOVUE, INC.
$100
Bausch & Lomb, a division of Bausch Health US, LLC
$60
Ocular Therapeutix, Inc.
$55
ANI Pharmaceuticals, Inc.
$27
Dutch Ophthalmic, USA
$20
Horizon Therapeutics plc
$15
Biogen, Inc.
$13
Retrophin, Inc.
$10
Top 3 companies account for 93.5% of total payments
Associated products mentioned in payments ›
(820) Cholbam · ACTHAR · BEOVU · CLARUS · Constellation · DEXTENZA · EVA · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · Hillrom - RetinaVue 700 Imager · ILUVIEN · Izervay · Lucentis · NFC-700 · Non-Covered Product · OZURDEX · One Series Ultra IOL Delivery System · PURIFIED CORTROPHIN GEL · Prokera · RXSIGHT CONTACT LENS · STELLARIS · SUSVIMO · Susvimo · Syfovre · TEPEZZA · Tecnis IOL · Tecnis Multifocal Family of 1-piece IOLS · Tecnis Simplicity · VABYSMO · Vabysmo · XIPERE · XR · YUTIQ · combined machine
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 3% for ophthalmology in TX.

Equivalent to $349 per 100 Medicare services performed
Looking for a ophthalmology in Austin?
Compare ophthalmologys in the Austin area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologys nearby

Geographic Context

Ophthalmologys within 10 mi
133
Per 100K population
10.2
County median income
$97,169
Nearest hospital
ASCENSION SETON MEDICAL CENTER AUSTIN
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Wong is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (consulting-driven, top 3%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Wong experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Wong performed 21,720 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wong receive payments from pharmaceutical companies?
Yes. Dr. Wong received a total of $112,670 from 33 companies across 164 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wong's costs compare to other ophthalmologys in Austin?
Dr. Wong's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wong) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →